Table 3.

Change in PA outcomes between baseline and follow-up, by study and randomization group)

	Bangladeshi		Filipino		Korean		Asian Indian
	Treatment (n=141)	Control (n=126)	Treatment (n=85)	Control (n=109)	Treatment (n=114)	Control (n=94)	Treatment (n=68)	Control (n=69)
Weekly moderate PA, minutes, median (IQR)
Baseline	0 (0-140)	0 (0-105)	180 (0-420)	210 (85-510)	60 (0-180)	90 (0-180)	0 (0-0)	0 (0-0)
Endpoint	140 (70-210)	90 (0-210)	290 (150-1200)	180 (120-720)	116 (0-240)	90 (0-180)	180 (150-210)	90 (60-150)
P-value BL to Endpoint1	<0.001	<0.001	<0.001	0.243	0.020	0.234	<0.001	<0.001
P-value T vs. C at Endpoint5	0.002		0.054		0.027		<0.001
Weekly vigorous PA, minutes, median (IQR)
Baseline	0 (0-0)	0 (0-0)	60.0 (0-240)	90.0 (0-210)	0 (0-80)	0 (0-120)	0 (0-0)	0 (0-0)
Endpoint	0 (0-0)	0 (0-0)	150.0 (30-360)	90 (0-210)	90 (0-180)	0 (0-120)	30 (0-60)	0 (0-0)
P-value BL to Endpoint1	0.011	0.026	0.056	0.508	<0.001	0.148	<0.001	0.039
P-value T vs. C at Endpoint5	0.009		0.048		0.005		<0.001
≥ Recommended weekly PA, n (%)
Baseline	39 (27.7)	37 (29.4)	64 (75.3)	84 (79.3)	56 (49.1)	50 (53.2)	7 (10.3)	7 (10.1)
Endpoint	80 (56.7)	53 (42.1)	78 (91.8)	96 (90.6)	72 (63.2)	46 (48.9)	64 (94.1)	25 (36.2)
P-value BL to Endpoint2	<0.001	0.030	0.002	0.007	0.011	0.527	<0.001	<0.001
P-value T vs. C at Endpoint4	0.017		0.773		0.039		<0.001
PA Self-Efficacy (1-4, 4=highest), mean (SD)
Baseline	3.3 (0.8)	3.3 (0.7)	3.2 (0.8)	3.3 (0.7)	3.0 (0.7)	3.0 (0.7)	3.2 (0.6)	3.2 (0.7)
Endpoint	3.7 (0.5)	3.4 (0.6)	3.7 (0.5)	3.4 (0.6)	3.2 (0.4)	2.9 (0.5)	3.9 (0.3)	3.3 (0.5)
P-value BL to Endpoint3	<0.001	0.386	<0.001	0.311	0.006	0.436	<0.001	0.939
P-value T vs. C at Endpoint6	<0.001		<0.001		<0.001		<0.001
PA Barriers (1-5, 5=most), mean (SD)
Baseline	1.4 (1.3)	1.5 (1.2)	0.7 (1.0)	0.8 (1.1)	0.9 (1.1)	1.0 (1.0)	2.4 (1.4)	2.5 (1.4)
Endpoint	0.9 (1.1)	1.1 (1.2)	0.4 (0.9)	0.7 (1.0)	0.8 (1.1)	1.0 (1.2)	1.1 (1.0)	1.8 (1.2)
P-value BL to Endpoint3	<0.001	0.004	0.021	0.282	0.304	0.843	<0.001	<0.001
P-value T vs. C at Endpoint6	0.178		0.070		0.132		<0.001
PA Social Interaction (1-4, 4=highest), mean (SD)
Baseline	n/a	n/a	2.5 (1.0)	2.4 (0.9)	2.1 (0.7)	2.1 (0.8)	1.5 (0.6)	1.5 (0.6)
Endpoint	n/a	n/a	2.9 (0.7)	2.4 (0.8)	2.2 (0.8)	2.0 (0.8)	3.2 (0.7)	2.0 (0.6)
P-value BL to Endpoint3	n/a	n/a	<0.001	0.965	0.253	0.223	<0.001	<0.001
P-value T vs. C at Endpoint6			<0.001		0.155		<0.001

Abbreviations: PA, physical activity; T, treatment; C, control; BL, baseline; IQR, interquartile range

¹Wilcoxon signed rank Test

²McNemar’s test

³Paired- samples t-test

⁴Chi-square test

⁵Wilcoxon rank sum test

⁶Independent samples t-test